SECUKINUMAB IMPROVES MINIMAL DISEASE ACTIVITY RESPONSE RATES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: DATA FROM THE RANDOMIZED PHASE 3 STUDY, FUTURE 2

被引：4
|
作者：
Coates, L. C. [1 ,2 ]
Mease, P. [3 ]
Kirkham, B. [4 ]
McLeod, L. D. [5 ]
Mpofu, S. [6 ]
Karyekar, C. [7 ]
Gandhi, K. [7 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[3] Univ Washington, Seattle, WA 98195 USA
[4] Guys & St Thomas NHS Fdn Trust, London, England
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
[6] Novartis Pharma AG, Basel, Switzerland
[7] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.3949
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0463
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [21] SECUKINUMAB INHIBITS RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS: DATA FROM A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (FUTURE 1)
    Van der Heijde, D.
    Landewe, R.
    Mease, P.
    McInnes, I. B.
    Conaghan, P. G.
    Pricop, L.
    Ligozio, G.
    Richards, H.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 347 - 348
  • [22] Secukinumab Improves Axial Manifestations in Patients with Psoriatic Arthritis and Inadequate Response to NSAIDs: Primary Analysis of Phase 3 Trial
    aBraliakos, Xenofon
    Coates, Laura
    Gossec, Laure
    Jeka, Slawomir
    Mera, Antonio
    Schulz, Barbara
    Rissler, Michael
    Das Gupta, Ayan
    Perella, Chiara
    Pournara, Effie
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS ACHIEVING MINIMAL DISEASE ACTIVITY WITH SECUKINUMAB TREATMENT DEMONSTRATE SUSTAINED IMPROVEMENT OF FUNCTION AND QUALITY OF LIFE
    Coates, Laura
    Mease, Philip
    Gossec, Laure
    Kirkham, Bruce
    Rasouliyan, Lawrence
    RHEUMATOLOGY, 2017, 56 : 79 - 80
  • [24] Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study
    Coates, Laura C.
    Mease, Philip J.
    Gossec, Laure
    Kirkham, Bruce
    Sherif, Bintu
    Gaillez, Corine
    Mpofu, Shephard
    Jugl, Steffen M.
    Karyekar, Chetan
    Gandhi, Kunal K.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (10) : 1529 - 1535
  • [25] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 4-YEAR RESULTS FROM THE PHASE 3 FUTURE 2 STUDY
    McInnes, Iain B.
    Kirkham, Bruce
    Nash, Peter
    Rahman, Proton
    Gottlieb, Alice B.
    Ding, Kevin
    Pricop, Luminita
    RHEUMATOLOGY, 2019, 58
  • [26] Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study
    Kivitz, Alan
    Sedova, Liliana
    Churchill, Melvin
    Kotha, Roshan
    Singhal, Atul
    Torres, Alexander
    Valenzuela, Guillermo
    Whelan, Sarah
    Dumortier, Thomas
    Zhu, Xuan
    Martin, Ruvie
    Pricop, Luminita
    ARTHRITIS & RHEUMATOLOGY, 2024,
  • [27] SECUKINUMAB PROVIDES SUSTAINED PASDAS RELATED LOW DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: 2 YEAR RESULTS FROM THE FUTURE 2 STUDY
    Coates, L. C.
    Gladman, D. D.
    Nash, P.
    Fitzgerald, O.
    Kavanaugh, A.
    Rasouliyan, L.
    Pricorp, L.
    Ding, K.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 948 - 949
  • [28] Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS) Related Remission: 2-Year Results from a Phase 3 Study
    Coates, Laura C.
    Gladman, Dafna D.
    Nash, Peter
    FitzGerald, Oliver
    Kavanaugh, Arthur
    Rasouliyan, Lawrence
    Pricop, Luminita
    Ding, Kevin
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] Secukinumab Provides Sustained Improvement in Major and Moderate Response of Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study
    Smolen, Josef S.
    Mease, Philip J.
    Ritchlin, Christopher T.
    Kvien, Tore K.
    Pricop, Luminita
    Fox, Todd
    Rasouliyan, Lawrence
    Jugl, Steffen
    Gaillez, Corine
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] Prediction of Low Disease Activity in Patients with Psoriatic Arthritis Treated with Secukinumab in Real World - Data from a German Observational Study
    Vodencarevic, Asmir
    Brandt-Juergens, Jan
    Peterlik, Daniel
    Gmeiner, Benjamin
    Kiltz, Uta
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 953 - 954
12345